📇 Rhumatologue ·
Chargement de la fiche…
Chargement de la fiche…
MonRhumato.fr utilise des cookies pour mesurer l'audience (statistiques) et améliorer le site. Aucune donnée de santé identifiable n'est jamais collectée. Politique de confidentialité.
Votre choix est conservé 13 mois (durée max CNIL). Vous pouvez le modifier à tout moment via Préférences cookies.
2 raisons identifiées
Auteur de référence en rhumatologie
34 articles scientifiques publiés — un praticien à la pointe de la recherche
Référence presse grand public
Cité 9 fois dans les médias — pédagogie reconnue
✨ Génération du profil synthétique IA en cours…
Indicateurs publics agrégés sur 250 M+ d'œuvres scientifiques (OpenAlex, PubMed). Traduits ici en langage patient.
Influence scientifique
23
23 articles ont été cités au moins 23fois par d'autres chercheurs — preuve que ses travaux sont repris par la communauté médicale.
Données ANS publiques (Licence Ouverte 2.0) · Enrichissements MonRhumato 100 % opt-in · Toute personne référencée peut demander la suppression ou la rectification.
h-index
Total citations reçues
1 909
Nombre de fois où d'autres équipes ont mentionné ses publications dans leurs propres travaux.
Publications totales
144
Articles, revues et chapitres référencés dans les bases académiques internationales.
Articles influents
49
Publications ayant marqué leur domaine — chacune citée au moins 10 fois par d'autres chercheurs.
i10-index
Thématiques principales
Source : OpenAlex (CC0, OurResearch). Indicateurs académiques agrégés sur 250 M+ d'œuvres.
Articles déposés en accès libre sur l'archive ouverte des universités françaises (HAL) — gage d'activité de recherche en France.
New quality factor to study the behavior of a solar panel
2023ArticleAuthorea Preprints
Numerical investigation and modelling of controllable parameters on the photovoltaic thermal collector efficiency in semi-humid climatic conditions
2022ArticleEnergy Sources, Part A
Human home daily living activities recognition based on a LabVIEW implemented hidden Markov model
2021ArticleMultimedia Tools and Applications
The DoE method as an efficient tool for modeling the behavior of monocrystalline Si-PV module
2018CongrèsTMREES18-Spring Meeting "Technologies and Materials for Renewable Energy, Environment and Sustainability"
Distributed photovoltaic architecture powering a DC bus: Impact of duty cycle and load variations on the efficiency of the generator
2018CongrèsTMREES18-Spring Meeting "Technologies and Materials for Renewable Energy, Environment and Sustainability"
Optimization by simulation of the nature of the buffer, the gap profile of the absorber and the thickness of the various layers in CZTSSe solar cells
2017ArticleMaterials Research Express
Renewable Energy Sources, the Internet of Things and the Third Industrial Revolution: Smart Grid and Contemporary Information and Communication Technologies
2016CongrèsTMREES16-Fall Meeting, European Edition. International Conference Technologies and Materials for Renewable Energy, Environment and Sustainability
Universal Transistor-based hardware SIMulator for real time simulation of photovoltaic generators
2016ArticleSolar Energy Materials
Source : HAL — archive ouverte CCSD/CNRS (couvre articles, chapitres EMC, communications congrès, thèses).
Secteur de conventionnement non disponible (médecin hospitalier ou non présent dans l'Annuaire santé CNAM des libéraux conventionnés).
Lien Doctolib = recherche Google site:doctolib.fr (le 1er résultat est presque toujours le profil correct s'il existe).
Source : Google News (recherche par nom complet — homonymes possibles, vérifier le contenu).
📰 lanouvellerepublique.fr · 06/03/2026
<a href="https://news.google.com/rss/articles/CBMi-AFBVV95cUxPLUhPZUEwZWlVZnVna0ZmYVlMRWNoQktzUHZMbzd5ekFUb0hwMFAyaEtCWDZiVXlkdF9XZ1RmSEc3bmtFcVRGaGNORzlod08wX3RVejdyRnVnb25HZnc4dTBVYldndTRpZThya0R4V0lZLXJreG1mXzBQYm90TFVWZTA4aGRtT25Jd2NHanIzaG00MUdOYWxSN1B5UTRBXzRzbkpaV1JGcmowWGR1RlRxR3RFTFFnZG1BVV
📰 Le Berry Républicain · 25/01/2023
<a href="https://news.google.com/rss/articles/CBMiyAFBVV95cUxNbFljQW5rMDhpMTA5S0xDWlM3ZHRPaURRN1puZG5ZOU9wS1ZIZHNOdEJ1MW9TMnM5Uk9PbkI1ZjRtM1ZYcG90dEEwd1pTYTBEVXJSVUhxdENJQURpVzh6V1VVNk5DdU5hejZubHNMN3JacG5RZzZRUWJIc09wdHB3ZEcyMm5ka25oVFZjV2ZacFB6ZC1hMkFSU3h2VWJpSjdxM2U0OHdmWUo1LUo2SkRQSVBuZDltaFhreU
📰 Le Berry Républicain · 22/09/2020
<a href="https://news.google.com/rss/articles/CBMi7wFBVV95cUxOZVdRV3djU2VEUkdCSnlONmpSaG9sS3gwNWRJUkI1a043Ullfb3V5UVBpeFF2dExqQ3NwRTBqRGl2UkowcXhsWGxlNlF5YjhOaEZJclVsNFdQMDV5QnZMaWd0T0M5ZFB1YTBPUE4ycVllWU01T3lUMDNYYnFMY2lpeF8wQ2ZEb0F1WEVyZjU3WUNvc21EOFF1UjM0SXozUm9QcU9rcmpNV0JGWF9RcEJIZWt2eG9CeDREQV
📰 Le Berry Républicain · 21/09/2020
<a href="https://news.google.com/rss/articles/CBMi-AFBVV95cUxNYjg0Rk9KUUpYaUhienkzOWdDSGlGc3ZiMnhHa2JiTmVabVVTV19WejM1OEFkLWFkay1SemszTEZuN2pWc1NnZGVpaGNpb2lsYzBoSUJuSzZQWldMRzl0WGtacUdpTDRlVUk4Qm1ZWmtVMU1TT000N3JwcTQxMDEtWGt5LTBuT3RaY1lueWpab25HOWdfR0hBWnpGajhoc1RPbnNHS05qVmpZdXl2UEJrTHdOMFd1QXppN2
📰 Le Berry Républicain · 01/10/2019
<a href="https://news.google.com/rss/articles/CBMimgFBVV95cUxOTk5HNmcyQkZYVGNTVUIwRDROOHpYczZHSElPX1ZKdDhIY2JGM1lKZ0w0LW1SLTdaa3pQaWZpWFdVMjY2TUVxbnBJUWItNlJsOTdfX200dmN0ek1sQ3QtN0FwazhJYUxUcnc4SFZlc3RzTW04eU9lZWRXdjVsMFpxRWpBczdEOF9NYVM5QU43Sk1GbUN0b0JCbmVB?oc=5" target="_blank">Jérémy Lacoffrette
📰 Le Berry Républicain · 18/10/2016
<a href="https://news.google.com/rss/articles/CBMilAFBVV95cUxQd3lQdkFyY29sLU9YSElNOEJDbDRUZlhvLXFGWlFpblR0Qzc3dVBiRC15N2lUZVhSSHF2Y3ctRTVMMzRfaGtvZXY3RjR2ekpJZzRFOW1DTzlIcDY5SGZaTDFFeEY2VUdtY3hPdzlzZmN6MG9sYkdiV0lURnRwM19GREVteWpsZGJzUFJBLVpFWmE2VkZG?oc=5" target="_blank">Un nouveau chef pour les po
📰 Le Berry Républicain · 27/05/2014
<a href="https://news.google.com/rss/articles/CBMizwFBVV95cUxPbTlEZFhLSk9zcGswNVFCNUhzbXN1dTFMd1gxUF9FRXhLR3A2RDhFdzhUYzdJYVJDWlhFUjVnRnZjeHQ0YTRvTW5rZV9GMXhKZFRSZVRCbEFuQ2ZyZ21CeHd0QTJZeVEtMURPSjYtNTY3RGRjOGlRS29zT3pfNWZ2U0lFX0lEajFKYVhvUlFadWQtZGN0T2FDR3dEWkxxN3ZYdzVoa29ONWpTVHdfZ1g0QU10TU9tNGd5eD
📰 Le Berry Républicain · 03/01/2013
<a href="https://news.google.com/rss/articles/CBMi4gFBVV95cUxPWEtMQ08xR0x0dWNXQ0N5YUlDbVMwcjZzcndONFduNVlwOTl0YnRuVlBmanBSZmFsc0tYTDlNTnU4T01MSndoUHJYTGFuVEI5VV9WeS1IdDR2OUYzYnNyV2h0ZzNkbHVRZzVIcHlzeXVMcTFVMTBFaXA4a3BQdWFPRmJReG02YUV3Z0NPVDU3aDZKbDA0elNIanpCekt0UldRUmR2Um5ZSl9TT3B4WTRTVU80aEozM0NEZE
📰 Le Berry Républicain · 07/12/2012
<a href="https://news.google.com/rss/articles/CBMipwFBVV95cUxNTVludWZuY29PVVFBdVpXWWs4VE81eHBIOGQwbks5RFBYQUJyT1NBZXIxeGxFZk5LTlc5eWxxV3Q0RmNjOGNONVZYN2ViODRMUVFKVzdUSkZxLVlLb0NiU1VyNlZCRFdmTUY4TUl4NkdHSUdGYXJkclk1SjdGTkdRaE1UbXJfZTZ1OFNKaWdZd05lUlBPaHpSR1h2cVhvRmMtMktYYXJFSQ?oc=5" target="_blank">L
Trends in molecular medicine · 2014
Arthritis & rheumatology (Hoboken, N.J.) · 2023
ObjectiveThe objective is to update recommendations for prevention and treatment of glucocorticoid‐induced osteoporosis (GIOP) for patients with rheumatic or nonrheumatic conditions receiving >3 months treatment with glucocorticoids (GCs) ≥2.5 mg daily.MethodsAn updated systematic literature review was performed for clinical questions on nonpharmacologic, pharmacologic treatments, discontinuation of medications, and sequential therapy. Grading of Recommendations Assessment, Development and Evaluation approach was used to rate the certainty of evidence. A Voting Panel achieved ≥70% consensus on the direction (for or against) and strength (strong or conditional) of recommendations.ResultsFor adults beginning or continuing >3 months of GC treatment, we strongly recommend as soon as possible after initiation of GCs, initial assessment of fracture risks with clinical fracture assessment, bone mineral density with vertebral fracture assessment or spinal x‐ray, and Fracture Risk Assessment Tool if ≥40 years old. For adults at medium, high, or very high fracture risk, we strongly recommend pharmacologic treatment. Choice of oral or intravenous bisphosphonates, denosumab, or parathyroid hormone analogs should be made by shared decision‐making. Anabolic agents are conditionally recommended as initial therapy for those with high and very high fracture risk. Recommendations are made for special populations, including children, people with organ transplants, people who may become pregnant, and people receiving very high‐dose GC treatment. New recommendations for both discontinuation of osteoporosis therapy and sequential therapies are included.ConclusionThis guideline provides direction for clinicians and patients making treatment decisions for management of GIOP. These recommendations should not be used to limit or deny access to therapies.
The Journal of experimental medicine · 2021
Osteoporosis is caused by an imbalance of osteoclasts and osteoblasts, occurring in close proximity to hematopoietic cells in the bone marrow. Recurrent somatic mutations that lead to an expanded population of mutant blood cells is termed clonal hematopoiesis of indeterminate potential (CHIP). Analyzing exome sequencing data from the UK Biobank, we found CHIP to be associated with increased incident osteoporosis diagnoses and decreased bone mineral density. In murine models, hematopoietic-specific mutations in Dnmt3a, the most commonly mutated gene in CHIP, decreased bone mass via increased osteoclastogenesis. Dnmt3a−/− demethylation opened chromatin and altered activity of inflammatory transcription factors. Bone loss was driven by proinflammatory cytokines, including Irf3-NF-κB–mediated IL-20 expression from Dnmt3a mutant macrophages. Increased osteoclastogenesis due to the Dnmt3a mutations was ameliorated by alendronate or IL-20 neutralization. These results demonstrate a novel source of osteoporosis-inducing inflammation.
Source PubMed · Recherche par auteur (homonymes possibles, vérifier l'affiliation).
Scientific reports · 2025 · Journal Article
Leite CBG, Bumberger A, Merkely G, Maietta K, et al.
Journal of visualized experiments : JoVE · 2025 · Journal Article
Leite CBG, Fricke HP, Song SD, Lattermann C, et al.
Osteoarthritis and cartilage · 2025 · Journal Article
Leite CBG, Fricke HP, Tavares LP, Nshimiyimana R, et al.
Arthritis care & research · 2024 · Comparative Study
Jandali B, Lyons M, Charles J, Zhang M, et al.
Journal of the American Medical Informatics Association : JAMIA · 2023 · Journal Article
Rodriguez JA, Charles JP, Bates DW, Lyles C, et al.
ACS nano · 2023 · Journal Article
Zhang C, Vedadghavami A, He T, Charles JF, et al.
Nature communications · 2022 · Journal Article
Huang Z, You X, Chen L, Du Y, et al.
Scandinavian journal of rheumatology · 2022 · Journal Article
Shaw AT, Yan J, Kuhstoss SA, Charles JF, et al.
ACR open rheumatology · 2022 · Journal Article
Jandali B, Salazar GA, Hudson M, Fritzler MJ, et al.
Bone · 2022 · Journal Article
Khedgikar V, Charles JF, Lehoczky JA
The Journal of experimental medicine · 2021 · Journal Article
Kim PG, Niroula A, Shkolnik V, McConkey M, et al.
The Journal of clinical investigation · 2021 · Journal Article
Levescot A, Chang MH, Schnell J, Nelson-Maney N, et al.
Seminars in arthritis and rheumatism · 2020 · Journal Article
Volkmann ER, Tashkin DP, Roth MD, Li N, et al.
Arthritis & rheumatology (Hoboken, N.J.) · 2019 · Evaluation Study
Volkmann ER, Tashkin DP, Kuwana M, Li N, et al.
The Journal of the American Academy of Orthopaedic Surgeons · 2019 · Journal Article
Matzkin EG, DeMaio M, Charles JF, Franklin CC
Future microbiology · 2019 · Journal Article
Moore AY, Charles JEM, Moore S
The Journal of rheumatology · 2018 · Journal Article
Salazar GA, Kuwana M, Wu M, Estrada-Y-Martin RM, et al.
Frontiers in nutrition · 2017 · Journal Article
Achamrah N, Coëffier M, Jésus P, Charles J, et al.
Arthritis & rheumatology (Hoboken, N.J.) · 2017 · Journal Article
Wu M, Baron M, Pedroza C, Salazar GA, et al.
Arthritis research & therapy · 2016 · Journal Article
Volkmann ER, Tashkin DP, Roth MD, Clements PJ, et al.
Arthritis & rheumatology (Hoboken, N.J.) · 2016 · Journal Article
O'Brien W, Fissel BM, Maeda Y, Yan J, et al.
Trends in molecular medicine · 2014 · Journal Article
Charles JF, Aliprantis AO
Arthritis and rheumatism · 2013 · Journal Article
Assassi S, Wu M, Tan FK, Chang J, et al.
Bone · 2012 · Journal Article
Charles JF, Coury F, Sulyanto R, Sitara D, et al.
Arthritis care & research · 2023 · Journal Article
Humphrey MB, Russell L, Danila MI, Fink HA, et al.
Arthritis & rheumatology (Hoboken, N.J.) · 2023 · Journal Article
Humphrey MB, Russell L, Danila MI, Fink HA, et al.
Arthritis care & research · 2023 · Journal Article
Humphrey MB, Russell L, Danila MI, Fink HA, et al.
Arthritis & rheumatology (Hoboken, N.J.) · 2023 · Journal Article
Humphrey MB, Russell L, Danila MI, Fink HA, et al.
Arthritis & rheumatology (Hoboken, N.J.) · 2025 · Comparative Study
Hanif I, Assassi S, Mayes MD, McMahan ZH, et al.
Seminars in arthritis and rheumatism · 2022 · Journal Article
Lam BH, Assassi S, Charles J, Taherian R, et al.
Cutis · 2010 · Case Reports
Moberg P, Charles JF, Respicio G, Venna SS, et al.
Kidney medicine · 2022 · Journal Article
Samal L, D'Amore JD, Gannon MP, Kilgallon JL, et al.
The American Journal of dermatopathology · 2025 · Journal Article
Ho JD, Charles J, Welch J, Fitz-Henley M, et al.
The Journal of rheumatology · 2015 · Comparative Study
Schmeling H, Mahler M, Levy DM, Moore K, et al.
Journal of foot and ankle research · 2026 · Journal Article
Tehan P, Azhar AN, Banwell H, Bergin S, et al.
Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases · 2011 · Case Reports
Malladi AS, Gratton SB, Stone D, Scalapino KJ, et al.
✨ Profil synthétique
IA · 19/05/2026M Jean-Pierre CHARLES est un rhumatologue avec une production scientifique importante, comme en témoigne son h-index de 23 et ses 144 publications. Cependant, ses thématiques de recherche semblent se concentrer sur les domaines des matériaux semiconducteurs et des technologies solaires, plutôt que sur la rhumatologie. Il est donc difficile de déduire des expertises spécifiques en rhumatologie à partir de ces informations.
Synthèse automatique à partir des sources publiques (HAL, OpenAlex, theses.fr, ClinicalTrials.gov, FAI²R, ANS). Pas une évaluation clinique. Le médecin peut corriger via son compte.